Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

transcreation

- PMLiVE

Moderna’s booster vaccines increase neutralising antibodies against COVID-19 variants

A single booster dose of the company's original vaccine or variant-specific candidate bolstered antibodies against two variants of concern

- PMLiVE

FDA approval for Keytruda/Herceptin combination in first-line advanced gastric cancer

Approval is based on positive overall response rate (ORR) data from KEYNOTE-811 trial

- PMLiVE

US backs proposal to waive IP protection for COVID-19 vaccines

"Monumental decision" could see IP protections for COVID-19 vaccines temporarily removed

- PMLiVE

Illingworth Research Group wins ‘prestigious’ Queen’s Award

Company recognised with a 2021 Queen’s Award for Enterprise for International Trade

- PMLiVE

bluebird bio aiming to separate business units by year-end

Biotech company has revealed that its new, separate oncology company will be named 2seventy bio

- PMLiVE

Nucleus Global appoints new regional director for Europe

Aycan Hassan-Walker will return to Europe following a stint working in the US

- PMLiVE

Virtual agency The Difference Collective makes new hires to senior team

Six senior healthcare communications consultants join the company's ranks

- PMLiVE

Merck & Co reveals plans for women’s health spinoff Organon

Company is expecting tax-free dividend of $9bn following close of spinoff

- PMLiVE

Deep 6 AI: the smart software breathing new life into clinical trials

Fishawack Health interviews Wout Brusselaers, the Deep 6 AI CEO using artificial intelligence to solve one of the greatest barriers stagnating healthcare innovation—clinical trial recruitment and retention.

Avalere Health

Oxford University Press adds new innovative ePrint options to its product portfolio for healthcare marketing and education

Two new ePrint packages offer a holistic and innovative solution to the traditional article reprint, ever popular at conferences and rep meetings. These new digital options allow extra content around...

Oxford University Press

- PMLiVE

Eli Lilly/AbCellera’s COVID-19 variant-targeting antibody enters clinical trials

Drug will be evaluted alone and together with other monoclonal antibodies in the expanded BLAZE-4 trial

- PMLiVE

Pfizer pauses enrolment for trial evaluating anti-BCMA bispecific antibody

Trial pause follows reports of three cases of peripheral neuropathy in phase 1 study

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links